Life sciences organizations face the challenge of converting great discoveries and research breakthroughs into public acceptance and market success. For companies specializing in pharmaceuticals, biotechnology, medical products and technology and medical devices, the life sciences are changing at a remarkable rate. Along with change come new challenges. The Physician Payments Sunshine Act, and other pending regulatory activity in the sector, are bringing a new era of transparency requirements to an evolving industry.
Watch our short video to learn ways life sciences companies are addressing the Sunshine Act and data concerns, new scrutiny for research and development (R&D) and stronger and more complex international enforcement.